Published on 7 Apr 2024 on Insider Monkey via Yahoo Finance

10 Best Weight Loss Drug Stocks to Buy Now

In this piece, we will take a look at the ten best weight loss drug stocks to buy now. If you want to skip our introduction to the rising weight loss drug industry and how it's one of the biggest trends on the stock market right now, then you can take a look at the 5 Best Weight Loss Drug Stocks to Buy Now.

While it's artificial intelligence that has dominated the stock market when it comes to technology stocks, in the non technology sector, it's weight loss drugs that are all the hype. The close of 2023 has seen Americans finally able to get their hands on a one stop solution for weight loss, which in turn has sent the shares of the firms that manufacture and sell these drugs skyrocketing. In fact, this trend is so strong that it's made some even wonder whether we'll see a non tech trillion dollar valuation soon as well.

At least this is what the investment bank Morgan Stanley believes about one of the premier weight loss drug stocks right now. This stock is Eli Lilly and Company (NYSE:LLY), and its latest market capitalization sits at a cool $745 billion. While Eli Lilly is in the news these days because of its weight loss drugs Mounjaro and Zepbound, it's one of the oldest pharmaceutical companies in the world since it was set up in 1876. So where does Morgan Stanley factor in all of this? Well, the shares currently trade at $784, and when combined with the outstanding shares of 950 million, this gives us the market cap figure quoted above.